at least IMHO
In January, we covered Aphria’s Q2 results. The company reported 19% growth in quarterly revenues and delivered its fourth consecutive quarter of profitability. In Q2, Aphria reported C$945,678 in net income, or C$0.01 per share. Profits rose due to strong growth in the average selling price per kilogram (or kilogram equivalent) and very strong new patient registrations in the quarter. Revenue for the three months ended November 30, 2016 was C$5,226,589, representing a 19.5% increased over the prior quarter’s revenue of C$4,375,512. The gross margin for Q2 was 77.4%.